130 related articles for article (PubMed ID: 935297)
1. Absorption of lithium following administration of slow-release and conventional preparations.
Tyrer S; Hullin RP; Birch NJ; Goodwin JC
Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
[TBL] [Abstract][Full Text] [Related]
2. Comparison of plasma lithium levels and their interindividual variations with coated lithium carbonate tablets and a medium-slow-release lithium sulphate preparation (Lithionit Duretter).
Persson G
Acta Psychiatr Scand; 1977 Feb; 55(2):147-52. PubMed ID: 320831
[TBL] [Abstract][Full Text] [Related]
3. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
Arancibia A; Corvalan F; Mella F; Concha L
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of standard and slow-release oral lithium carbonate products.
Wallis J; Miller R; McFadyen ML; Carlile JB
S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a slow-release lithium carbonate formulation.
Cooper TB; Simpson GM; Lee JH; Bergner PE
Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of lithium preparations in patients.
Johnson GF; Hunt GE
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.
Ciftçi K; Capan Y; Oztürk O; Hincal AA
Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020
[TBL] [Abstract][Full Text] [Related]
8. Aspect of the pharmacokinetics of slow-release lithium carbonate.
Hart GA
S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
[TBL] [Abstract][Full Text] [Related]
10. Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (Lithium lipett C) and lithium carbonate tablets.
Persson G
Acta Psychiatr Scand; 1974; 50(2):174-82. PubMed ID: 4853671
[No Abstract] [Full Text] [Related]
11. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
Kauko K; Viukari M
Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
[No Abstract] [Full Text] [Related]
12. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
[TBL] [Abstract][Full Text] [Related]
13. Comparison of side effects with coated lithium carbonate tablets and lithium sulphate preparations giving medium-slow and slow-release.
Edström A; Persson G
Acta Psychiatr Scand; 1977 Feb; 55(2):153-8. PubMed ID: 320832
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
Johnson GF; Hunt GE; Lewis J; St George B
Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
[TBL] [Abstract][Full Text] [Related]
15. Lithium absorption from sustained-release tablets (Duretter).
Amdisen A; Sjögren J
Acta Pharm Suec; 1968 Nov; 5(5):465-72. PubMed ID: 5732567
[No Abstract] [Full Text] [Related]
16. Single-dose bioavailability of two extended-release lithium carbonate products.
Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
[TBL] [Abstract][Full Text] [Related]
17. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
Castrogiovanni P
Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of sustained-release tablets of lithium in a fat matrix and its bioavailability in humans.
Llabrés M; Fariña JB
J Pharm Sci; 1991 Nov; 80(11):1012-6. PubMed ID: 1815050
[TBL] [Abstract][Full Text] [Related]
19. Absorption & urinary & salivary excretion of lithium after oral administration.
Doshi BS; Rout SJ; Kulkarni RD
Indian J Med Res; 1983 Nov; 78():708-12. PubMed ID: 6423533
[No Abstract] [Full Text] [Related]
20. Lithium absorption from ordinary and from sustained-release tablets.
Otto U; Paalzow L; Surén G
Acta Pharm Suec; 1972 Dec; 9(6):595-601. PubMed ID: 4656566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
